Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2006
The purpose of this study is to compare the reactogenicity \& safety of Tritanrix™-HepB/Hib-MenAC vaccine to the international standard of care, Tritanrix™-HepB/Hiberix™.
Epistemonikos ID: 51359822d0ab2970de960f10ce632ec6839321ac
First added on: Nov 24, 2021